72 Participants Needed

Oral Food Challenge for Food Intolerance

(INFINITY Trial)

Recruiting at 1 trial location
AN
JC
Overseen ByJoseline Cruz Vazquez, MPH
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new method to diagnose food protein-induced enterocolitis syndrome (FPIES), a condition that causes severe digestive reactions to certain foods. The researchers aim to determine the optimal dose for a low-dose, multi-day oral food challenge, which involves gradually consuming small amounts of food to observe if symptoms are triggered. Participants will test different doses of food protein, either at home (At-Home Low-Dose Oral Food Challenge) or under supervision (Supervised High-Dose Oral Food Challenge or Supervised Low-Dose Oral Food Challenge). This trial suits individuals aged 1-60 who have previously experienced an FPIES reaction and can identify symptoms like severe vomiting or diarrhea after consuming certain foods. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research in diagnosing FPIES.

Will I have to stop taking my current medications?

The trial requires participants to stop taking certain medications for 7 days before the screening visit and throughout the study, unless they are needed as rescue medications.

What prior data suggests that this protocol is safe for diagnosing FPIES?

Research has shown that oral food challenges (OFCs) are generally safe for diagnosing food allergies. An OFC involves consuming small amounts of the suspected food allergen under medical supervision to monitor for reactions. Studies have found that low-dose OFCs are particularly well-tolerated. In one study, infants under one year safely consumed small amounts of allergenic foods without severe reactions.

The supervised high-dose OFC is also considered safe, though the risk of a reaction increases with the larger amount of allergen. Medical staff are present to manage any reactions that may occur during these tests.

Overall, while reactions can occur, they are usually mild and manageable. The medical team ensures participants' safety throughout the process.12345

Why are researchers excited about this trial?

Researchers are excited about the Oral Food Challenge (OFC) trial for food intolerance because it explores different approaches to manage and potentially improve food tolerance in a controlled and measured way. Unlike standard treatments that often involve strict avoidance or gradual introduction of allergens, this trial is testing various doses of food proteins to see how they can be safely reintroduced. The trial includes both at-home low-dose and supervised high-dose challenges, which could offer more flexibility and insight into personalized treatment plans for individuals with food intolerances. By examining how different doses affect tolerance, the trial may pave the way for more tailored, effective strategies to manage food intolerance, ultimately improving patient quality of life.

What evidence suggests that this trial's treatments could be effective for diagnosing food protein-induced enterocolitis syndrome?

Research has shown that oral food challenges (OFCs) reliably test for food allergies, including food protein-induced enterocolitis syndrome (FPIES). These tests diagnose food allergies by gradually introducing the suspected allergen and observing any reactions. In this trial, participants will undergo various types of OFCs. Some will take part in at-home low-dose OFCs, which studies recommend for safely diagnosing food allergies, as they provide crucial information about a person's sensitivity to certain foods. Others will participate in supervised high-dose OFCs, which are valuable for helping patients learn about and manage their food allergies. These methods enable doctors to better understand the severity and management of food allergies.14678

Who Is on the Research Team?

AN

Anna Nowak-Wegrzyn, MD, PhD

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for individuals aged 1-60 with suspected or confirmed food protein-induced enterocolitis syndrome (FPIES), a condition causing digestive distress after eating certain foods. Details on who can't join are not provided.

Inclusion Criteria

I am between 1 and 60 years old.
Suspected or confirmed FPIES diagnosis
Reported convincing FPIES reaction within specified time frames
See 3 more

Exclusion Criteria

IgE-mediated food allergies where the trigger has not been identified
Inability to discontinue prohibited medications for specified duration
I have been diagnosed with high blood pressure.
See 20 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Baseline

Participants complete a baseline gastrointestinal symptom diary

1 day
1 visit (in-person)

Low Dose Oral Food Challenge

Participants undergo a supervised Low Dose OFC to their FPIES trigger

1 day
1 visit (in-person)

Home Challenge

Participants who do not react at the Day 1 Low Dose OFC continue with a daily home challenge

6 days
Daily monitoring (home-based)

High Dose Oral Food Challenge

Participants who tolerated the home challenges undergo a High Dose OFC

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the challenges

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • At-Home Low-Dose Oral Food Challenge
  • Supervised High-Dose Oral Food Challenge
  • Supervised Low-Dose Oral Food Challenge
Trial Overview The study tests different ways to diagnose FPIES using oral food challenges: high-dose and low-dose supervised in a clinic, and low-dose at home. It aims to find the safest and most effective dose for these tests.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Cohort 3Experimental Treatment3 Interventions
Group II: Cohort 2Experimental Treatment3 Interventions
Group III: Cohort 1Experimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborator

Trials
3,361
Recruited
5,516,000+

Published Research Related to This Trial

In a study of 365 children undergoing food challenges, 40% tested positive for food allergies, with 7% reacting to as little as 1 mg of protein, indicating that early responses can occur and highlighting the need for careful monitoring during testing.
The study found that achieving the recommended cumulative dose of 3,500 mg of allergen protein was not feasible for most children using the gingerbread matrix, suggesting that lower cumulative doses could be effective without increasing the risk of false negatives.
Feasibility and Reaction Thresholds of Double-Blind, Placebo-Controlled Peanut and Nut Food Challenges Using Gingerbread Matrix.van de Vorst-van der Velde, K., Andela, P., de Groot, H., et al.[2023]
Food allergies in children are common, but only a small number have clinically relevant allergies, primarily to foods like cow's milk, eggs, peanuts, and tree nuts.
The double-blind, placebo-controlled food challenge remains the gold standard for diagnosing food allergies, despite the need for improved standardization in its procedure to ensure accurate results and avoid unnecessary dietary restrictions.
Diagnosis of food allergy in children: toward a standardization of food challenge.Niggemann, B., Beyer, K.[2017]
A study involving 114 patients with peanut allergy demonstrated that a three-level stepwise oral food challenge (OFC) using peanut butter is safe, with only one participant requiring adrenaline during the highest dose.
The OFC showed positive reactions in 52% of participants at the lowest dose (0.1g), decreasing to 20% at the highest dose (3g), indicating that reactions are more common at lower doses, which is important for assessing allergy severity.
[SAFETY OF A THREE-LEVEL STEPWISE ORAL FOOD CHALLENGE FOR PEANUT ALLERGY].Nihei, M., Sato, T., Horino, S., et al.[2019]

Citations

Evaluating the efficacy of a novel home-based oral food ...Food protein–induced enterocolitis syndrome (FPIES) is a non-immunoglobulin E (IgE)-mediated food allergy, predominantly affecting infants [1].
Efficacy of very-low-dose oral food challenge in children ...In Japan, HE allergy accounts for 39% of immediate-type food allergies, making it a predominant allergen encountered in pediatric clinical practice. The ...
Low‐dose oral food challenges - Takei - 2024... food allergy recommends low-dose oral food challenges ... However, data regarding OFCs performed in infants aged <1 year with food allergies ...
Will Oral Food Challenges Still Be Part of Allergy Care ...However, OFCs can also provide additional phenotypic information about the allergy, such as sensitivity to the allergen (ie, whether the patient ...
Oral Food ChallengeAn oral food challenge is a highly accurate diagnostic test for food allergies. Learn about the three types and how they work.
Food Allergy: Oral Food ChallengeYou Might Also Be Interested In. Shellfish. Blog. Food Allergy vs. Intolerance: Knowing the Difference.
Will Oral Food Challenges Still Be Part of Allergy Care in ...However, OFCs can also provide additional phenotypic information about the allergy, such as sensitivity to the allergen (ie, whether the patient requires a ...
Oral Food Challenge (OFC): Test, Risks & ResultsIgE-mediated means that IgE allergy antibodies cause the allergic reaction. These types of allergies typically produce an immediate reaction to a food. Test ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security